Abstract
The threat of fungal diseases is substantially underestimated worldwide, but they have serious consequences for humans, animals, and plants. Given the limited number of existing antifungal drugs together with the emergence of drug-resistant strains, many researchers have actively sought alternatives or adjuvants to antimycotics. The best way to tackle these issues is to unearth potential antifungal agents with new modes of action. Antimicrobial peptides are being hailed as a promising source of novel antimicrobials since they exhibit rapid and broad-spectrum microbicidal activities with a reduced likelihood of developing drug resistance. Recent years have witnessed an explosion in knowledge on microbicidal activity of LL-37, the sole human cathelicidin. Herein, we provide a summary of the current understanding about antifungal properties of LL-37, with particular emphasis on its molecular mechanisms. We further illustrate fruitful areas for future research. LL-37 is able to inhibit the growth of clinically and agronomically relevant fungi including Aspergillus, Candida, Colletotrichum, Fusarium, Malassezia, Pythium, and Trichophyton. Destruction of the cell wall integrity, membrane permeabilization, induction of oxidative stress, disruption of endoplasmic reticulum homeostasis, formation of autophagy-like structures, alterations in expression of numerous fungal genes, and inhibition of cell cycle progression are the key mechanisms underlying antifungal effects of LL-37. Burgeoning evidence also suggests that LL-37 may act as a potential anti-virulence peptide. It is hoped that this review will not only motivate researchers to conduct more detailed studies in this field, but also inspire further innovations in the design of LL-37-based drugs for the treatment of fungal infections.
Graphical abstract
Similar content being viewed by others
Data availability
Not applicable.
References
Abo Nouh FA, Gezaf SA, Abdel-Azeem AM (2020) Mycotoxins: potential as biocontrol agents. In: Yadav A, Mishra S, Kour D, Yadav N, Kumar A (eds) Agriculturally important fungi for sustainable sgriculture. Fungal biology. Springer, Cham.
Adedara IA, Owumi SE (2023) Neurobehavioral and biochemical responses to artemisinin-based drug and aflatoxin B co-exposure in rats. Mycotoxin Res 39(1):67–80
Agerberth B, Buentke E, Bergman P, Eshaghi H, Gabrielsson S, Gudmundsson GH, Scheynius A (2006) Malassezia sympodialis differently affects the expression of LL-37 in dendritic cells from atopic eczema patients and healthy individuals. Allergy 61(4):422–430
Aghazadeh H, Memariani H, Ranjbar R, Pooshang Bagheri K (2019) The activity and action mechanism of novel short selective LL-37‐derived anticancer peptides against clinical isolates of Escherichia coli. Chem Biol Drug Des 93(1):75–83
Alford MA, Baquir B, Santana FL, Haney EF, Hancock RE (2020) Cathelicidin host defense peptides and inflammatory signaling: striking a balance. Front Microbiol 11:1902
Alves V, Araújo GRS, Frases S (2023) Off-label treatments as potential accelerators in the search for the ideal antifungal treatment of cryptococcosis. Future Microbiol 18:127–35
Aref S, Nouri S, Moravvej H, Memariani M, Memariani H (2022) Epidemiology of dermatophytosis in Tehran, Iran: a ten-year retrospective study. Arch Iran Med 25(8):502–507
Arendrup MC, Patterson TF (2017) Multidrug-resistant Candida: epidemiology, molecular mechanisms, and treatment. J Infect Dis 216(suppl3):S445–S451
Atiencia-Carrera MB, Cabezas-Mera FS, Tejera E, Machado A (2022) Prevalence of biofilms in Candida spp. bloodstream infections: a meta-analysis. PLoS ONE 17(2):e0263522
Ballard E, Yucel R, Melchers WJ, Brown AJ, Verweij PE, Warris A (2020) Antifungal activity of antimicrobial peptides and proteins against. J Fungi 6:65
Benjamin AB, Moule MG, Didwania MK, Hardy J, Saenkham-Huntsinger P, Sule P, Nielsen JE, Lin JS, Contag CH, Barron AE, Cirillo JD (2022) Efficacy of cathelicidin-mimetic antimicrobial peptoids against Staphylococcus aureus. Microbiol Spectr 10(3):e00534-22
Bongomin F, Gago S, Oladele RO, Denning DW (2017) Global and multi-national prevalence of fungal diseases—estimate precision. J Fungi 3(4):57
Brackin AP, Hemmings SJ, Fisher MC, Rhodes J (2021) Fungal genomics in respiratory medicine: what, how and when? Mycopathologia 186:589–608
Braff MH, Hawkins MI, Nardo AD, Lopez-Garcia B, Howell MD, Wong C, Lin K, Streib JE, Dorschner R, Leung DY, Gallo RL (2005) Structure-function relationships among human cathelicidin peptides: dissociation of antimicrobial properties from host immunostimulatory activities. J Immunol 174(7):4271–4278
Cassin ME, Ford AJ, Orbach SM, Saverot SE, Rajagopalan P (2016) The design of antimicrobial LL37-modified collagen-hyaluronic acid detachable multilayers. Acta Biomater 40:119–129
Celestrino GA, Verrinder Veasey J, Benard G, Sousa MGT (2021) Host immune responses in dermatophytes infection. Mycoses 64(5):477–483
Chaffin WL (2008) Cell wall proteins. Microbiol Mol Biol Rev 72(3):495–544
Chang HT, Tsai PW, Huang HH, Liu YS, Chien TS, Lan CY (2012) LL37 and hBD-3 elevate the β-1, 3-exoglucanase activity of Candida albicans Xog1p, resulting in reduced fungal adhesion to plastic. Biochem J 441(3):963–970
Chen YC, Chen FJ, Lee CH (2021) Effect of antifungal agents, lysozyme and human antimicrobial peptide LL-37 on clinical Candida isolates with high biofilm production. J Med Microbiol 70(2):001283
Childers DS, Avelar GM, Bain JM, Pradhan A, Larcombe DE, Netea MG, Erwig LP, Gow NA, Brown AJ (2020) Epitope shaving promotes fungal immune evasion. MBio 11(4): e00984-20
Ciornei CD, Sigurdardóttir T, Schmidtchen A, Bodelsson M (2005) Antimicrobial and chemoattractant activity, lipopolysaccharide neutralization, cytotoxicity, and inhibition by serum of analogs of human cathelicidin LL-37. Antimicrob Agents Chemother 49(7):2845–2850
da Silva LL, Moreno HL, Correia HL, Santana MF, de Queiroz MV (2020) Colletotrichum: species complexes, lifestyle, and peculiarities of some sources of genetic variability. Appl Microbiol Biotechnol 104:1891–1904
Daly P, Zhou D, Shen D, Chen Y, Xue T, Chen S, Zhang Q, Zhang J, McGowan J, Cai F, Pang G (2022) Genome of Pythium myriotylum uncovers an extensive arsenal of virulence-related genes among the broad-host-range necrotrophic Pythium plant pathogens. Microbiol Spectr 10(4):e02268-21
Datta S, Roy A (2021) Antimicrobial peptides as potential therapeutic agents: a review. Int J Pept Res Ther 27:555–577
de Souza GHDA, Rossato L, de Oliveira AR, Simionatto S (2023) Antimicrobial peptides against polymyxin-resistant Klebsiella pneumoniae: a patent review. World J Microbiol Biotechnol 39(3):86
Dell’Olmo E, Tiberini A, Sigillo L (2023) Leguminous seedborne pathogens: seed health and sustainable crop management. Plants 12(10):2040
den Hertog AL, van Marle J, van Veen HA, Van’t Hof W, Bolscher JGM, Veerman ECI, Amerongen AVN (2005) Candidacidal effects of two antimicrobial peptides: histatin 5 causes small membrane defects, but LL-37 causes massive disruption of the cell membrane. Biochem J 388(Pt 2):689–695
den Hertog AL, van Marle J, Veerman EC, Valentijn-Benz M, Nazmi K, Kalay H, Grün CH, Van’t Hof W, Bolscher JG, Nieuw Amerongen AV (2006) The human cathelicidin peptide LL-37 and truncated variants induce segregation of lipids and proteins in the plasma membrane of Candida albicans. Biol Chem 387(10–11):1495–1502
Denardi LB, Weiblen C, Ianiski LB, Stibbe PC, Pinto SC, Santurio JM (2022) Anti-Pythium insidiosum activity of MSI-78, LL-37, and magainin-2 antimicrobial peptides. Braz J Microbiol 53(1):509–512
Desai JV, Bruno VM, Ganguly S, Stamper RJ, Mitchell KF, Solis N, Hill EM, Xu W, Filler SG, Andes DR, Fanning S, Lanni F, Mitchell AP (2013) Regulatory role of glycerol in Candida albicans biofilm formation. MBio 4(2):e00637-12
Dijksteel GS, Ulrich MM, Middelkoop E, Boekema BK (2021) Lessons learned from clinical trials using antimicrobial peptides (AMPs). Front Microbiol 12:616979
Dorschner RA, Lopez-Garcia B, Massie J, Kim C, Gallo RL (2004) Innate immune defense of the nail unit by antimicrobial peptides. J Am Acad Dermatol 50(3):343–348
Durnaś B, Wnorowska U, Pogoda K, Deptuła P, Wątek M, Piktel E, Głuszek S, Gu X, Savage PB, Niemirowicz K, Bucki R (2016) Candidacidal activity of selected ceragenins and human cathelicidin LL-37 in experimental settings mimicking infection sites. PLoS ONE 11(6):e0157242
Elmowafy EM, Tiboni M, Soliman ME (2019) Biocompatibility, biodegradation and biomedical applications of poly (lactic acid)/poly (lactic-co-glycolic acid) micro and nanoparticles. J Pharm Investig 49:347–380
Ernst JF, Pla J (2011) Signaling the glycoshield: maintenance of the Candida albicans cell wall. Int J Med Microbiol 301(5):378–383
Fernandes AR, Mira NP, Vargas RC, Canelhas I, Sá-Correia I (2005) Saccharomy cescerevisiae adaptation to weak acids involves the transcription factor Haa1p and Haa1p-regulated genes. Biochem Biophys Res Commun 337(1):95–103
Fernández de Ullivarri M, Arbulu S, Garcia-Gutierrez E, Cotter PD (2020) Antifungal peptides as therapeutic agents. Front Cell Infect Microbiol 10:105
Finkel JS, Xu W, Huang D, Hill EM, Desai JV, Woolford CA, Nett JE, Taff H, Norice CT, Andes DR, Lanni F (2012) Portrait of Candida albicans adherence regulators. PLoS Pathog 8(2):e1002525
Fritz P, Beck-Jendroschek V, Brasch J (2012) Inhibition of dermatophytes by the antimicrobial peptides human β-defensin-2, ribonuclease 7 and psoriasin. Med Mycol 50(6):579–584
Gallagher L, Owens RA, Dolan SK, O’Keeffe G, Schrettl M, Kavanagh K, Jones GW, Doyle S (2012) The Aspergillus fumigatus protein GliK protects against oxidative stress and is essential for gliotoxin biosynthesis. Eukaryot Cell 11(10):1226–1238
Gan BH, Gaynord J, Rowe SM, Deingruber T, Spring DR (2021) The multifaceted nature of antimicrobial peptides: current synthetic chemistry approaches and future directions. Chem Soc Rev 50(13):7820–7880
Gauwerky K, Borelli C, Korting HC (2009) Targeting virulence: a new paradigm for antifungals. Drug Discov Today 14(3–4):214–222
Gbian DL, Omri A (2022) Lipid-based drug delivery systems for diseases managements. Biomedicines 10(9):2137
Gwyer Findlay E, Currie SM, Davidson DJ (2013) Cationic host defence peptides: potential as antiviral therapeutics. BioDrugs 27:479–493
Hacioglu M, Oyardi O, Bozkurt-Guzel C, Savage PB (2020) Antibiofilm activities of ceragenins and antimicrobial peptides against fungal-bacterial mono and multispecies biofims. J Antibiot 73(7):455–462
Han Q, Wang N, Yao G, Mu C, Wang Y, Sang J (2019) Blocking β-1,6‐glucan synthesis by deleting KRE6 and SKN1 attenuates the virulence of Candida albicans. Mol Microbiol 111(3):604–620
Holani R, Rathnayaka C, Blyth GA, Babbar A, Lahiri P, Young D, Dufour A, Hollenberg MD, McKay DM, Cobo ER (2023) Cathelicidins induce toll-interacting protein synthesis to prevent apoptosis in colonic epithelium. J Innate Immun 15:204–221
Hsu CM, Liao YL, Chang CK, Lan CY (2021) Sfp1 is involved in the cell wall and endoplasmic reticulum stress responses induced by human antimicrobial peptide LL-37. Int J Mol Sci 22:10633
Jacobs SE, Walsh TJ (2023) Non-Aspergillus hyaline molds: a host-based perspective of emerging pathogenic fungi causing sinopulmonary diseases. J Fungi (Basel) 9(2):212
Jung YJ, Lee SY, Moon YS, Kang KK (2012) Enhanced resistance to bacterial and fungal pathogens by overexpression of a human cathelicidin antimicrobial peptide (hCAP18/LL-37) in Chinese cabbage. Plant Biotechnol Rep 6:39–46
Kamysz E, Sikorska E, Karafova A, Dawgul M (2012) Synthesis, biological activity and conformational analysis of head-to‐tail cyclic analogues of LL37 and histatin 5. J Pept Sci 18(9):560–566
Kamysz E, Sikorska E, Jaśkiewicz M, Bauer M, Neubauer D, Bartoszewska S, Barańska-Rybak W, Kamysz W (2020) Lipidated analogs of the LL-37-derived peptide fragment KR12—structural analysis, surface-active properties and antimicrobial activity. Int J Mol Sci 21(3):88
Kong E, Jabra-Rizk MA (2015) The great escape: pathogen versus host. PLoS Pathog 11(3):e1004661
Kraidlova L, Schrevens S, Tournu H, Van Zeebroeck G, Sychrova H, Van Dijck P (2016) Characterization of the Candidaalbicans amino acid permease family: Gap2 is the only general amino acid permease and Gap4 is an S-adenosylmethionine (SAM) transporter required for SAM-induced morphogenesis. mSphere 1(6):e00284-16
Kurniadi I, Wijaya H, Timotius KH (2022) Virulence factors and their role in dermatological disorders. Acta Dermatovenerol Alp Pannonica Adriat 31(2):65–70
Ledoux MP, Herbrecht R (2023) Invasive pulmonary aspergillosis. J Fungi (Basel) 9(2):131
Lima SMF, Freire MS, Gomes ALO, Cantuária APC, Dutra FRP, Magalhães BS, Sousa MGC, Migliolo L, Almeida JA, Franco OL, Rezende TMB (2017) Antimicrobial and immunomodulatory activity of host defense peptides, clavanins and LL-37, in vitro: an endodontic perspective. Peptides 95:16–24
Lin X, Wang R, Mai S (2020) Advances in delivery systems for the therapeutic application of LL37. J Drug Deliv Sci Technol 60:102016
López-García B, Lee PH, Yamasaki K, Gallo RL (2005) Anti-fungal activity of cathelicidins and their potential role in Candidaalbicans skin infection. J Invest Dermatol 125(1):108–115. https://doi.org/10.1111/j.0022-202X.2005.23713.x
López-García B, Lee PH, Gallo RL (2006) Expression and potential function of cathelicidin antimicrobial peptides in dermatophytosis and tinea versicolor. J Antimicrob Chemother 57(5):877–882. https://doi.org/10.1093/jac/dkl078
Lu F, Zhu Y, Zhang G, Liu Z (2022) Renovation as innovation: repurposing human antibacterial peptide LL-37 for cancer therapy. Front Pharmacol 13:944147
Luo L, Tong X, Farley PC (2007) The Candida albicans gene HGT12 (orf19. 7094) encodes a hexose transporter. FEMS Immunol Med Microbiol 51(1):14–17. https://doi.org/10.1111/j.1574-695X.2007.00274.x
Luo Y, McLean DT, Linden GJ, McAuley DF, McMullan R, Lundy FT (2017) The naturally occurring host defense peptide, LL-37, and its truncated mimetics KE-18 and KR-12 have selected biocidal and antibiofilm activities against Candidaalbicans, Staphylococcusaureus, and Escherichiacoli in vitro. Front Microbiol 8:544
Luo XL, Li JX, Huang HR, Duan JL, Dai RX, Tao RJ, Yang L, Hou JY, Jia XM, Xu JF (2019) LL37 inhibits Aspergillus fumigatus infection via directly binding to the fungus and preventing excessive inflammation. Front Immunol 10:283. https://doi.org/10.3389/fimmu.2019.00283
Martin H, Kavanagh K, Velasco-Torrijos T (2021) Targeting adhesion in fungal pathogen. Future Med Chem 13(03):313–334
Maximiano MR, Rios TB, Campos ML, Prado GS, Dias SC, Franco OL (2022) Nanoparticles in association with antimicrobial peptides (NanoAMPs) as a promising combination for agriculture development. Front Mol Biosci 9:890654. https://doi.org/10.3389/fmolb.2022.890654
Memariani H, Memariani M (2020) Anti-fungal properties and mechanisms of melittin. Appl Microbiol Biotechnol 104(15):6513–6526
Memariani H, Memariani M (2023) Antibiofilm properties of cathelicidin LL-37: an in-depth review. World J Microbiol Biotechnol 39:99. https://doi.org/10.1007/s11274-023-03545-z
Memariani H, Shahbazzadeh D, Ranjbar R, Behdani M, Memariani M, Pooshang Bagheri K (2017) Design and characterization of short hybrid antimicrobial peptides from pEM-2, mastoparan‐VT 1, and mastoparan‐B. Chem Biol Drug Des 89(3):327–338
Memariani H, Shahbazzadeh D, Sabatier JM, Pooshang Bagheri K (2018) Membrane-active peptide PV3 efficiently eradicates multidrug‐resistant Pseudomonas aeruginosa in a mouse model of burn infection. APMIS 126(2):114–122
Memariani H, Memariani M, Robati RM, Nasiri S, Abdollahimajd F, Baseri Z, Moravvej H (2020) Anti-staphylococcal and cytotoxic activities of the short anti-microbial peptide PVP. World J Microbiol Biotechnol 36(11):174
Memariani M, Memariani H, Poursafavi Z, Baseri Z (2022) Antifungal effects and mechanisms of action of wasp venom-derived peptide mastoparan-VT1 against Candida albicans. Int J Pept Res Ther 28:96. https://doi.org/10.1007/s10989-022-10401-5
Memariani M, Memariani H, Moravvej H, Goudarzi H, Robati RM (2023) Anticandidal activity and mechanism of action of several cationic chimeric antimicrobial peptides. Int J Pept Res Ther 29(3):50
Méndez-Samperio P (2004) Peptidomimetics as a new generation of antimicrobial agents: current progress. Infect Drug Resist 7:229–237
Menzel LP, Chowdhury HM, Masso-Silva JA, Ruddick W, Falkovsky K, Vorona R, Malsbary A, Cherabuddi K, Ryan LK, DiFranco KM, Brice DC, Costanzo MJ, Weaver D, Freeman KB, Scott RW, Diamond G (2017) Potent in vitro and in vivo antifungal activity of a small molecule host defense peptide mimic through a membrane-active mechanism. Sci Rep 7(1):4353
Mercer DK, O’Neil DA (2020) Innate inspiration: antifungal peptides and other immunotherapeutics from the host immune response. Front Immunol 11:2177
Mirzaee M, Holásková E, Mičúchová A, Kopečný DJ, Osmani Z, Frébort I (2021) Long-lasting stable expression of human LL-37 antimicrobial peptide in transgenic barley plants. Antibiotics 10(8):898
Mosallam S, Albash R, Abdelbari MA (2022) Advanced vesicular systems for antifungal drug delivery. AAPS PharmSciTech 23:206
Murad AM, Leng P, Straffon M, Wishart J, Macaskill S, MacCallum D, Schnell N, Talibi D, Marechal D, Tekaia F, d’Enfert C, Gaillardin C, Odds FC, Brown AJP (2001) NRG1 represses yeast–hypha morphogenesis and hypha-specific gene expression in Candida albicans. EMBO J 20(17):4742–4752
Murakami M, Lopez-Garcia B, Braff M, Dorschner RA, Gallo RL (2004) Postsecretory processing generates multiple cathelicidins for enhanced topical antimicrobial defense. J Immunol 172(5):3070–3077
Niemirowicz K, Durnaś B, Tokajuk G, Piktel E, Michalak G, Gu X, Kułakowska A, Savage PB, Bucki R (2017) Formulation and candidacidal activity of magnetic nanoparticles coated with cathelicidin LL-37 and ceragenin CSA-13. Sci Rep 7:4610
Nordström R, Nyström L, Andrén OC, Malkoch M, Umerska A, Davoudi M, Schmidtchen A, Malmsten M (2018) Membrane interactions of microgels as carriers of antimicrobial peptides. J Colloid Interface Sci 513:141–150. https://doi.org/10.1016/j.jcis.2017.11.014
Ooi EH, Wormald PJ, Carney AS, James CL, Tan LW (2007) Fungal allergens induce cathelicidin LL-37 expression in chronic rhinosinusitis patients in a nasal explant model. Am J Rhinol 21(3):367–372
Ordonez SR, Amarullah IH, Wubbolts RW, Veldhuizen EJ, Haagsman HP (2014) Fungicidal mechanisms of cathelicidins LL-37 and CATH-2 revealed by live-cell imaging. Antimicrob Agents Chemother 58(4):2240–2248
Oshiro KG, Rodrigues G, Monges BE, Cardoso MH, Franco OL (2019) Bioactive peptides against fungal biofilms. Front Microbiol 10:2169. https://doi.org/10.3389/fmicb.2019.02169
Radojević ID, Jakovljević VD, Ostojić AM (2023) A mini-review on indigenous microbial biofilm from various wastewater for heavy-metal removal - new trends. World J Microbiol Biotechnol 39:309
Rather IA, Sabir JS, Asseri AH, Ali S (2022) Antifungal activity of human cathelicidin LL-37, a membrane disrupting peptide, by triggering oxidative stress and cell cycle arrest in Candidaauris. J Fungi 8(2):204
Read A, Schröder M (2021) The unfolded protein response: an overview. Biology 10(5):384
Reen FJ, Phelan JP, Gallagher L, Woods DF, Shanahan RM, Cano R, ÓMuimhneacháin E, McGlacken GP, O’Gara F (2016) Exploiting interkingdom interactions for development of small-molecule inhibitors of bioflm formation. Antimicrob Agents Chemother 60(10):5894–5905. https://doi.org/10.1128/AAC.00190-16
Rhimi W, Theelen B, Boekhout T, Otranto D, Cafarchia C (2020) Malassezia spp. yeasts of emerging concern in fungemia. Front Cell Infect Microbiol 10:370. https://doi.org/10.3389/fcimb.2020.00370
Rodríguez-Castaño GP, Rosenau F, Ständker L, Firacative C (2023) Antimicrobial peptides: avant-garde antifungal agents to fight against medically important. Species Pharm 15(3):789
Russo A, Tiseo G, Falcone M, Menichetti F (2020) Pulmonary aspergillosis: an evolving challenge for diagnosis and treatment. Infect Dis Ther 9:511–524
Scarsini M, Tomasinsig L, Arzese A, D’Este F, Oro D, Skerlavaj B (2015) Antifungal activity of cathelicidin peptides against planktonic and biofilm cultures of Candida species isolated from vaginal infections. Peptides 71:211–221. https://doi.org/10.1016/j.peptides.2015.07.023
Shanmugaraj B, Bulaon CJI, Malla A, Phoolcharoen W (2021) Biotechnological insights on the expression and production of antimicrobial peptides in plants. Molecules 26(13):4032
Sheehan G, Bergsson G, McElvaney NG, Reeves EP, Kavanagh K (2018) The human cathelicidin antimicrobial peptide LL-37 promotes the growth of the pulmonary pathogen Aspergillus fumigatus. Infect Immun 86(7):e00097-18
Sieprawska-Lupa M, Mydel P, Krawczyk K, Wójcik K, Puklo M, Lupa B, Suder P, Silberring J, Reed M, Pohl J, Shafer W, McAleese F, Foster T, Travis J, Potempa J (2004) Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases. Antimicrob Agents Chemother 48(12):4673–4679
Sigurdardottir T, Andersson P, Davoudi M, Malmsten M, Schmidtchen A, Bodelsson M (2006) In silico identification and biological evaluation of antimicrobial peptides based on human cathelicidin LL-37. Antimicrob Agents Chemother 50(9):2983–2989
Sonesson A, Ringstad L, Nordahl EA, Malmsten M, Mörgelin M, Schmidtchen A (2007) Antifungal activity of C3a and C3a-derived peptides against. Biochim Biophys Acta 1768(2):346–353
Sugui JA, Kwon-Chung KJ, Juvvadi PR, Latgé JP, Steinbach WJ (2015) Aspergillus fumigatus and related species. Cold Spring Harb Perspect Med 5(2):a019786
Thompson GR III, Young JA (2021) AspergillusInfections. N Engl J Med 385(16):1496–1509
Tornesello AL, Borrelli A, Buonaguro L, Buonaguro FM, Tornesello ML (2020) Antimicrobial peptides as anticancer agents: functional properties and biological activities. Molecules 25(12):2850
Tsai PW, Yang CY, Chang HT, Lan CY (2011a) Human antimicrobial peptide LL-37 inhibits adhesion of Candida albicans by interacting with yeast cell-wall carbohydrates. PloS One 6(3):e17755
Tsai PW, Yang CY, Chang HT, Lan CY (2011b) Characterizing the role of cell-wall β-1, 3-exoglucanase Xog1p in Candida albicans adhesion by the human antimicrobial peptide LL-37. PLoS One 6(6):e21394. https://doi.org/10.1371/journal.pone.0021394
Tsai PW, Cheng YL, Hsieh WP, Lan CY (2014) Responses of candida albicans to the human antimicrobial peptide LL-37. J Microbiol 52:581–589. https://doi.org/10.1007/s12275-014-3630-2
van Der Weerden NL, Hancock RE, Anderson MA (2010) Permeabilization of fungal hyphae by the plant defensin NaD1 occurs through a cell wall-dependent process. J Biol Chem 285(48):37513–37520
Van Eijk M, Boerefijn S, Cen L, Rosa M, Morren MJ, Van Der Ent CK, Kraak B, Dijksterhuis J, Valdes ID, Haagsman HP, De Cock H (2020) Cathelicidin-inspired antimicrobial peptides as novel antifungal compounds. Med Mycol 58(8):1073–1084. https://doi.org/10.1093/mmy/myaa014
Vanreppelen G, Wuyts J, Van Dijck P, Vandecruys P (2023) Sources of antifungal Drugs. J Fungi 9(2):171. https://doi.org/10.3390/jof9020171
Wang G (2008) Structures of human host defense cathelicidin LL-37 and its smallest antimicrobial peptide KR-12 in lipid micelles. J Biol Chem 283(47):32637–32643. https://doi.org/10.1074/jbc.M805533200
Wang G, Narayana JL, Mishra B, Zhang Y, Wang F, Wang C, Zarena D, Lushnikova T, Wang X (2019) Design of antimicrobial peptides: progress made with human cathelicidin LL-37. In: Matsuzaki K (ed) Antimicrobial peptides. Advances in experimental medicine and biology, vol 1117. Springer, Singapore. https://doi.org/10.1007/978-981-13-3588-4_12
Wong JH, Ng TB, Legowska A, Rolka K, Hui M, Cho CH (2011) Antifungal action of human cathelicidin fragment (LL13–37) on Candida albicans. Peptides 32(10):1996–2002
Wooten DJ, Zañudo JGT, Murrugarra D, Perry AM, Dongari-Bagtzoglou A, Laubenbacher R, Nobile CJ, Albert R (2021) Mathematical modeling of the Candida albicans yeast to hyphal transition reveals novel control strategies. PLoS Comput Biol 17(3):e1008690
Wu H, Liu S, Wiradharma N, Ong ZY, Li Y, Yang YY, Ying JY (2017) Short synthetic α-helical‐forming peptide amphiphiles for fungal keratitis treatment in vivo. Adv Healthc Mater 6(6):1600777
Yarbrough VL, Winkle S, Herbst-Kralovetz MM (2015) Antimicrobial peptides in the female reproductive tract: a critical component of the mucosal immune barrier with physiological and clinical implications. Hum Reprod Update 21(3):353–377
Yu H, Liu X, Wang C, Qiao X, Wu S, Wang H, Feng L, Wang Y (2016a) Assessing the potential of four cathelicidins for the management of mouse candidiasis and Candida albicans biofilms. Biochimie 121:268–277
Yu Q, Zhang B, Li J, Zhang B, Wang H, Li M (2016b) Endoplasmic reticulum-derived reactive oxygen species (ROS) is involved in toxicity of cell wall stress to Candida albicans. Free Radic Biol Med 99:572–583
Yun H, Min HJ, Lee CW (2020) NMR structure and bactericidal activity of KR-12 analog derived from human LL-37 as a potential cosmetic preservative. J Anal Sci Technol 11:14
Zhang Y, Wu J, Xin Z, Wu X (2014) Triggers innate immune response via NOD1 signaling in human corneal epithelial cells. Exp Eye Res 127:170–178
Acknowledgements
Not applicable.
Funding
The authors declare that no funds, grants, or other support were received during the preparation of this manuscript.
Author information
Authors and Affiliations
Contributions
H.M. contributed to the conception of the study. M.M. collected the data. M.M. and H.M. jointly wrote the manuscript. H.M. reviewed and edited the manuscript. Both authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflicts of interest.
Ethical approval
Not applicable.
Consent to participate
Not applicable.
Consent for publication
Both authors gave final approval for publication.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Memariani, M., Memariani, H. Antifungal properties of cathelicidin LL-37: current knowledge and future research directions. World J Microbiol Biotechnol 40, 34 (2024). https://doi.org/10.1007/s11274-023-03852-5
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11274-023-03852-5